Welcome to our dedicated page for Waterdrop news (Ticker: WDH), a resource for investors and traders seeking the latest updates and insights on Waterdrop stock.
Waterdrop Inc. (NYSE: WDH) is a technology platform dedicated to insurance and healthcare services, and its news flow centers on business performance, AI deployment, and social impact. Regular announcements include unaudited quarterly financial results, where the company reports net operating revenue, net profit attributable to ordinary shareholders, and segment performance across insurance, crowdfunding, and digital clinical trial solutions.
News about Waterdrop’s insurance business often highlights insurance-related income, first-year premiums generated through its insurance marketplace, and the contribution of technical service income. Disclosures describe how AI tools such as the AI Medical Insurance Expert, KEYI.AI underwriting assistant, and AI Customer Service Agent are used to improve underwriting efficiency, handle customer inquiries, and support sales and service processes.
Updates on Waterdrop Medical Crowdfunding typically provide cumulative figures for donors, total donations, and patients supported, alongside descriptions of enhanced risk control frameworks, anti-fraud analytics, and donor evaluation systems. The company also releases information on its digital clinical trial solution and E-Find Platform, including patient enrollment numbers, the number of clinical trial programs served, and collaborations with pharmaceutical and contract research organizations.
Investors following WDH news will also see announcements about share repurchase programs, cash dividends, and conference call schedules for financial results. In addition, Waterdrop has reported recognition such as inclusion of its “Waterdrop: AI-Powered Insurance and Healthcare” case in the Harvard Business School Case Collection, underscoring external interest in its AI-powered insurance and healthcare model. For users tracking WDH, this news page aggregates these financial, operational, and corporate updates in one place.
Waterdrop Inc. (NYSE: WDH), a technology platform focused on insurance and healthcare services, has scheduled its first quarter 2025 financial results announcement for June 5, 2025, before U.S. markets open. The company will host a conference call at 8:00 AM U.S. Eastern Time (8:00 PM Beijing/Hong Kong Time) on the same day to discuss the results.
The earnings call will offer both Chinese and English interpretation lines, with the English line being listen-only. The conference call replay will be available until June 12, 2025. Investors can also access the live and archived webcasts through Waterdrop's investor relations website.
Waterdrop reported strong financial results for 2024, with net revenue of RMB 2.772 billion and net profit of RMB 368 million, marking a 119.8% year-over-year increase. The company maintained profitability for 12 consecutive quarters and completed a share buyback of 52.1 million ADS for US$100 million.
Key highlights include:
- Insurance Business: RMB 7.473 billion in first-year premiums, RMB 2.36 billion revenue
- Medical Crowdfunding: 3.4 million patients helped, RMB 67.5 billion raised from 470 million donors
- Digital Clinical Trials: RMB 91.1 million revenue, 10,395 patients enrolled
The company's AI investments of RMB 300 million annually have yielded significant results, with AI-powered solutions reducing query resolution time by 50%. Major financial institutions including Goldman Sachs maintain Buy ratings, projecting 20% revenue growth for 2025.
Waterdrop (NYSE: WDH), a technology platform focused on insurance and healthcare services, has announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2024. The report was submitted to the U.S. Securities and Exchange Commission on April 25, 2025.
The annual report is accessible through Waterdrop's investor relations website and the SEC's website. Shareholders can request a complimentary hard copy of the annual report, which includes audited consolidated financial statements, by contacting the company's IR Department.
Goldman Sachs has maintained a 'Buy' rating for Waterdrop (WDH) with a 12-month price target of US$1.80 per ADS. The company reported strong financial results for 2024, with net profit reaching 368 million yuan (US$51 million), up 119.8% year-over-year.
The company's Q4 2024 first-year premium (FYP) for insurance business grew 24.5% to 1.9 billion yuan (US$263 million). WDH announced a cash dividend of US$0.02 per ADS for Q4, totaling US$0.04 for FY2024. The company has repurchased 52.1 million ADSs worth US$100 million since September 2021.
As an early adopter of AI LLMs, Waterdrop invests 300 million yuan annually in R&D and has over 100 technology patents. The company projects 20% revenue growth for 2025, though increased business expansion investments may impact profit margins.
Waterdrop Inc. (WDH) received a 'Buy' rating from UOB Kay Hian with a price target of US$2.20 per ADS. The company reported strong financial results, with Q4 2024 net operating revenue of 687 million yuan (US$95 million) and net profit of 99.62 million yuan (US$13.8 million). Full-year 2024 performance showed net operating revenue of 2.772 billion yuan (US$384 million) and net profit of 368 million yuan (US$51 million), marking a 119.8% year-on-year increase.
UOB Kay Hian projects a five-year compound annual growth rate of 25.0% in net profit from 2023 to 2028. The company maintains a stable operating margin above 20% in its insurance segment and invests approximately 300 million yuan annually in R&D. Waterdrop has implemented AI LLMs, including the DeepSeek model, to enhance service capabilities and improve efficiency by 50% through its AI Service Assistant, Bao Xiaohui.
Waterdrop (NYSE: WDH) reported strong financial results for Q4 and FY2024. The company's annual net profit surged 119.8% year-over-year to RMB 367.5 million, while net operating revenue increased 5.4% to RMB 2,771.8 million.
Q4 highlights include net operating revenue of RMB 686.8 million and net profit of RMB 99.6 million, up 68.5% YoY. The insurance business generated RMB1,897.9 million in first-year premiums (FYP), a 24.5% YoY increase. Annual insurance operating profit reached RMB 477.2 million.
The company declared a cash dividend of US$0.02 per ADS, payable in May 2025. As of February 2025, Waterdrop has repurchased approximately 52.1 million ADSs for US$103.7 million. The company's cash position stood at RMB3,670.3 million (US$502.8 million) at year-end.
Notable achievements include the integration of DeepSeek AI models for insurance services and official recognition as a pioneer in China's standardized medical crowdfunding sector.
Waterdrop Inc. (NYSE: WDH), a technology platform focused on insurance and healthcare services, has announced a significant board change. Mr. Chen Lin has been appointed as an independent director and audit committee member, effective March 11, 2025, replacing Mr. Ning Zhu who resigned for personal reasons.
Lin brings extensive academic and professional experience, serving as Chair of Finance and Stelux Professor at The University of Hong Kong since 2013 and Associate Vice President since 2023. He holds multiple independent directorships in various companies and serves on several prestigious committees, including the Hang Seng Index Advisory Committee and the Task Force on Promoting Web3 Development of Hong Kong.
The new director holds a PhD in economics, an MBA, and has significant expertise in finance and technology sectors. Waterdrop's CEO Peng Shen expressed confidence that Lin's professional background and industry expertise will contribute significantly to the company's mission.
Waterdrop Inc. (NYSE: WDH) reported strong Q4 2024 financial results, with net profit reaching RMB99.6 million (US$13.6 million), up 68.7% year-over-year. The company's insurance business generated first-year premiums of RMB1,897.9 million, increasing 24.5% YoY, while net operating revenue grew 4.2% to RMB686.8 million.
Key highlights include expanded crowdfunding coverage reaching 470 million donors and RMB67.5 billion in donations, successful patient recruitment with 10,395 patients enrolled in clinical trials, and strategic AI integration with DeepSeek models. The company announced a new cash dividend of US$7.3 million and has repurchased 52.1 million ADSs from the open market.
For full-year 2024, net operating revenue increased 5.4% to RMB2,771.8 million, with net profit reaching RMB367.5 million, marking a 119.8% YoY increase. The company maintains a strong cash position of RMB3,670.3 million as of December 31, 2024.